High Tower Advisors, LLC Dare Bioscience, Inc. Transaction History

High Tower Advisors, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$0.31 - $0.57 $11,129 - $20,463	-35,900 Reduced 76.87%	10,800 $5,000
Q4 2023 Feb 12, 2024	BUY	$0.29 - $0.53 $10,440 - $19,080	36,000 Added 336.45%	46,700 $14,000
Q2 2023 Aug 14, 2023	SELL	$0.91 - $1.05 $5,460 - $6,300	-6,000 Reduced 35.93%	10,700 $9,000
Q1 2023 May 11, 2023	SELL	$0.87 - $1.36 $3,480 - $5,441	-4,001 Reduced 19.33%	16,700 $17,000
Q4 2022 Feb 08, 2023	SELL	$0.82 - $12.6 $4,373 - $67,208	-5,334 Reduced 20.49%	20,701 $17,000
Q3 2022 Nov 09, 2022	SELL	$1.04 - $12.48 $37,440 - $449,280	-36,000 Reduced 58.03%	26,035 $26,000
Q2 2022 Aug 10, 2022	BUY	$0.94 - $1.76 $30,080 - $56,320	32,000 Added 106.54%	62,035 $76,000
Q1 2022 May 12, 2022	BUY	$1.42 - $2.09 $10,466 - $15,405	7,371 Added 32.52%	30,035 $45,000
Q4 2021 Feb 10, 2022	BUY	$1.42 - $2.13 $893 - $1,339	629 Added 2.85%	22,664 $45,000
Q3 2021 Nov 12, 2021	SELL	$1.42 - $2.0 $11,360 - $16,000	-8,000 Reduced 26.64%	22,035 $36,000
Q2 2021 Aug 06, 2021	BUY	$1.21 - $1.89 $16,940 - $26,460	14,000 Added 87.31%	30,035 $57,000
Q1 2021 May 10, 2021	SELL	$1.31 - $3.0 $20,958 - $47,997	-15,999 Reduced 49.94%	16,035 $27,000
Q4 2020 Feb 10, 2021	BUY	$0.96 - $1.51 $7,680 - $12,080	8,000 Added 33.29%	32,034 $42,000
Q3 2020 Nov 13, 2020	SELL	$0.98 - $1.52 $1,960 - $3,040	-2,000 Reduced 7.68%	24,034 $24,000
Q2 2020 Aug 10, 2020	BUY	$0.84 - $1.11 $8,400 - $11,100	10,000 Added 62.37%	26,034 $26,000
Q1 2020 May 21, 2020	BUY	$0.79 - $1.7 $12,666 - $27,257	16,034 New	16,034 $14,000

267K

Ticker DARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,820,896
Market Cap $270M
Description
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.